Long-term experience with mycophenolate mofetilin liver transplantation for HCV-related cirrhosis.

被引:0
|
作者
Avolio, A. W.
Agnes, S.
Siciliano, M.
Nure, E.
Grillo, R.
Barbarino, R.
Pompili, M.
Frongillo, F.
Pepe, G.
Castagneto, M.
机构
[1] Catholic Univ Policlin A Gemelli, Transplantat Serv, Rome, Italy
[2] Catholic Univ Policlin A Gemelli, Microbiol Serv, Rome, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:C83 / C83
页数:1
相关论文
共 50 条
  • [1] Impact of HIV coinfection on the long-term follow-up of HCV-related cirrhosis.
    Di Martino, V
    Ezenfis, J
    Tainturier, MK
    Benhamou, Y
    Bochet, M
    Opolon, P
    Poynard, T
    HEPATOLOGY, 2000, 32 (04) : 212A - 212A
  • [2] The natural history of HCV-related cirrhosis after liver transplantation
    Clark, V. C.
    Firpi, R. J.
    Soldevila-Pico, C.
    Morelli, G.
    Cabrera, R.
    Levy, C.
    Machicao, V. I.
    Chen, C.
    Nelson, D. R.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S3 - S3
  • [3] The natural history of compensated HCV-related cirrhosis: A prospective long-term study
    Vilar Gomez, Eduardo
    Sanchez Rodriguez, Yoan
    Calzadilla Bertot, Luis
    Torres Gonzalez, Ana
    Martinez Perez, Yadina
    Arus Soler, Enrique
    Yasells Garcia, Ali
    Perez Blanco, Luis
    JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 434 - 444
  • [4] MIP-1 alpha expression in HCV-recurrence after orthotopic liver transplantation (OLT) for HCV-related cirrhosis.
    Ferrara, C
    Burra, P
    Bortolami, M
    Tessari, G
    Fagiuoli, S
    Poletti, A
    Giaccon, C
    Cecchetto, A
    Farinati, F
    Chiaramonte, M
    Naccarato, R
    HEPATOLOGY, 1998, 28 (04) : 560A - 560A
  • [5] Severe recurrent hepatitis C following liver re-transplantation (LT) for HCV-related graft cirrhosis.
    Berenguer, M
    Palau, A
    Moreno, R
    Prieto, M
    Carrasco, D
    Benlloch, S
    Berenguer, J
    HEPATOLOGY, 2002, 36 (04) : 179A - 179A
  • [6] Evolution of the genetic complexity of the hepatitis C virus (HCV) hypervariable 1 region after liver transplantation (LT) for HCV-related cirrhosis.
    Pawlotsky, JM
    Pellerin, M
    Duvoux, C
    Pellet, C
    Cherqui, D
    Josse, JM
    Dupont, C
    Darthuy, F
    Remire, J
    Zafrani, ES
    Duval, J
    Dhumeaux, D
    HEPATOLOGY, 1996, 24 (04) : 1735 - 1735
  • [7] Increased survival of patients with HCV-related cirrhosis with a long-term response to interferon therapy
    Viganò, M
    Aghemo, A
    Iavarone, MA
    Lampertico, P
    Rumi, MG
    Sangiovanni, A
    Del Ninno, E
    Colombo, M
    HEPATOLOGY, 2005, 42 (04) : 432A - 432A
  • [8] The Effect of Splenectomy and Subsequent Interferon Therapy in Patients With HCV-Related Liver Cirrhosis in the Long Term
    Inagaki, Yuji
    Yamamoto, Norihiko
    Shiraki, Katsuya
    Yada, Takazumi
    Yoshizawa, Naohiko
    Beppu, Tetsuya
    Sugimoto, Kazushi
    Ogura, Suguru
    Tameda, Masahiko
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Takei, Yoshiyuki
    Sakurai, Hiroyuki
    Isaji, Shuji
    GASTROENTEROLOGY, 2013, 144 (05) : S984 - S984
  • [9] The Long-Term Effect of Antiviral Therapy on the Development of Liver Failure and Hepatocellular Carcinoma in Patients With Compensated HCV-Related Cirrhosis
    Sermsathanasawadi, Radsamee
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn P.
    Srisajjakul, Sitthipong
    Pausawasdi, Nonthalee
    Nimanong, Supot
    Prachayakul, Varayu
    Pongprasobchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Sataporn
    Kachintorn, Udom
    Tanwandee, Tawesak
    GASTROENTEROLOGY, 2010, 138 (05) : S841 - S842
  • [10] The long-term clinical outcomes of patients with HCV-related compensated cirrhosis and history of parenteral exposure
    Hu, KO
    Tong, MJ
    GASTROENTEROLOGY, 1998, 114 (04) : A1258 - A1259